Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma
Clinical trial NCT03248128 · COMPLETED
Trial details
- NCT number
- NCT03248128
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-20
- Primary completion
- 2022-03-21
- Enrollment
- 906
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.